NCT00098150 Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis Status COMPLETED Phase N/A
NCT00098046 Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection Status COMPLETED Phase PHASE3
NCT00094146 Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity Status COMPLETED Phase PHASE2
NCT00088231 PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP Status COMPLETED Phase PHASE1/PHASE2
NCT00081874 RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00058188 Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation Status TERMINATED Phase PHASE3
NCT00057265 A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B Status COMPLETED Phase PHASE3
NCT00056459 Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE3
NCT00050531 High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML) Status COMPLETED Phase PHASE3
NCT00049959 Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. Status TERMINATED Phase PHASE3
NCT00038194 Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer Status COMPLETED Phase PHASE1
NCT00029224 Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions Status COMPLETED Phase PHASE4
NCT00014638 Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE4
NCT00006475 STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis Status COMPLETED Phase PHASE2
NCT00006343 STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE3
NCT00006269 Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer Status TERMINATED Phase PHASE3
NCT00006053 STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa Status COMPLETED Phase PHASE2
NCT00006052 STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE2
NCT00003884 Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone Status COMPLETED Phase PHASE3